医学
糖尿病
回顾性队列研究
梅德林
重症监护医学
真实世界的证据
内科学
内分泌学
政治学
法学
标识
DOI:10.1016/j.ekir.2024.02.121
摘要
Finerenone is effective and safe in chronic kidney disease (CKD) with type 2 diabetes mellitus (T2DM) in phase III clinical trials. However, no data from clinical trials and real-world is available on the effectiveness of finerenone in CKD patients without diabetes mellitus(DM).
科研通智能强力驱动
Strongly Powered by AbleSci AI